Business Wire

03 Jun 2026, 20:45 UTC · 1h ago

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics

Read original · https://www.businesswire.com/news/home/20260603131911/en/Alnylam-and-Inceptive-Form-Strategic-AI-Collaboration-to-Accelerate-the-Discovery-of-RNAi-Therapeutics/

Search tags

Story key points

2 claims · impact-rated

What matters in this story

1
Alnylam Pharmaceuticals entered a strategic collaboration with Inceptive Nucleics valued at up to $2 billion. — A multi-billion dollar investment in foundation models for life suggests a major scale-up in R&D efficiency and pipeline potential.
+0.60
2
The agreement includes an upfront consideration of $30 million consisting of cash and equity purchase. — The upfront payment is a relatively small immediate cash outflow compared to the total potential deal value.
+0.20

Ticker attribution

Model heads

Sentiment in this article

ALNY+0.60
The company entered a strategic collaboration to accelerate therapeutic innovation via AI foundation models.

6 related stories

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate t… · News Impact Screener

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics

What matters in this story

Sentiment in this article

GSK plc (GSK) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Google's AI Overviews search feature will be impacted by a ‘world first' rule in the U.K. Here's what will change

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics

What matters in this story

Sentiment in this article

GSK plc (GSK) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Google's AI Overviews search feature will be impacted by a ‘world first' rule in the U.K. Here's what will change

Relationships in this article

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Simulation Plus, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws

Broadcom revenue hits record on AI chip surge but outlook disappoints

CrowdStrike narrowly beats estimates on AI tailwinds, but stock falls 9%

RGC FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - RGC

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics

What matters in this story

Sentiment in this article

Next reads from the same story arc

GSK plc (GSK) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Google's AI Overviews search feature will be impacted by a ‘world first' rule in the U.K. Here's what will change

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics

What matters in this story

Sentiment in this article

Next reads from the same story arc

GSK plc (GSK) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Google's AI Overviews search feature will be impacted by a ‘world first' rule in the U.K. Here's what will change

Relationships in this article

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Simulation Plus, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws

Broadcom revenue hits record on AI chip surge but outlook disappoints

CrowdStrike narrowly beats estimates on AI tailwinds, but stock falls 9%

RGC FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - RGC